Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis
Yee Shen Loo1, Tse Yee Wong1, Sajesh K Veettil2
1School of Pharmacy, International University Medical, Kuala Lumpur, Malaysia.
Objective:
This review examined the comparative efficacy and safety of antifungal agents in preventing oral candidiasis among patients on cancer treatment.
Methods:
We performed a systematic review and network meta-analysis based on randomised controlled trials that compared antifungal agents to placebo or other antifungal agents used in patients undergoing cancer treatment. Relative ranking of antifungal agents was evaluated with surface under the cumulative ranking (SUCRA) probability score. A total of 20 randomised controlled trials (3,215 participants) comparing 11 interventions were included.
Results:
Compared with placebo, clotrimazole was ranked the best agent for preventing the incidence of oral candidiasis (risk ratio (RR), 0.21 [95% CI 0.08 to 0.55]; SUCRA = 0.89). Fluconazole was ranked the safest among other antifungal agents (SUCRA = 0.80), whereas clotrimazole (SUCRA = 0.36) and amphotericin B (SUCRA = 0.18) were ranked low for safety. Amphotericin B was associated with highest risk of adverse events (RR, 3.52 [95% CI 1.27 to 9.75]).
Conclusion:
Clotrimazole is the most effective in preventing oral candidiasis, whereas fluconazole has the most favourable risk-benefit profile in patients undergoing cancer treatment. However, we are unable to recommend clotrimazole as the best choice to prevent oral candidiasis due to unavailability of studies comparing clotrimazole with other antifungal agents.
Insights
Clotrimazole best prevents oral candidiasis in cancer patients, while fluconazole offers the best safety profile. Further research is needed to confirm clotrimazole
Area of Science:
- Oncology
- Infectious Diseases
- Pharmacology
Background:
- Cancer patients undergoing treatment are at high risk for opportunistic infections like oral candidiasis.
- Antifungal prophylaxis is crucial for managing and preventing oral candidiasis in this vulnerable population.
- Comparative data on the efficacy and safety of various antifungal agents is essential for clinical decision-making.
Purpose of the Study:
- To systematically review and network meta-analyze the comparative efficacy and safety of antifungal agents for preventing oral candidiasis in cancer patients.
- To rank antifungal agents based on their effectiveness and safety profiles using surface under the cumulative ranking (SUCRA) scores.
Main Methods:
- Systematic review and network meta-analysis of randomized controlled trials (RCTs).
- Inclusion of 20 RCTs with 3,215 participants comparing 11 antifungal interventions against placebo or other antifungals.
- Evaluation of relative rankings using SUCRA probability scores.
Main Results:
- Clotrimazole demonstrated the highest efficacy in preventing oral candidiasis compared to placebo (RR, 0.21; SUCRA = 0.89).
- Fluconazole was ranked highest for safety among antifungal agents (SUCRA = 0.80).
- Amphotericin B showed the highest risk of adverse events (RR, 3.52) and was ranked low for safety (SUCRA = 0.18), as was clotrimazole (SUCRA = 0.36).
Conclusions:
- Clotrimazole is the most effective agent for preventing oral candidiasis in cancer patients.
- Fluconazole possesses the most favorable risk-benefit profile.
- Despite its efficacy, clotrimazole cannot be definitively recommended due to a lack of direct comparative studies with other antifungals.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Antimicrobial Effectiveness

